Skip to navigation Skip to content

No quick fix for COVID-19 vaccine hesitancy among UK South Asian communities

The complex, multiple factors influencing COVID-19 vaccine hesitancy and scepticism among UK South Asian communities mean ‘quick fix’ solutions to increase uptake of the vaccines will be ineffective, according to new research published by JRSM Open.

The researchers, from Imperial College London and City University of London, interviewed patients and healthcare professionals to explore views among South Asians on the COVID-19 vaccine, including their decision-making on whether or not to vaccinate.

Dr Raj Chandok, lead author of the study and a GP working in Southall, London, said: “Before COVID-19, the relationship of all our participants with vaccines seems to have been easy and unproblematic. However, in the COVID-19 era, it was clear from the outset that their concerns and hesitancies were specific to these particular vaccines.”

A key finding of the research was that a lack of trust operated on multiple levels in perpetuating vaccine hesitancy, with a lack of trust in healthcare authorities, Government and various media platforms present among most of the participants.

The researchers say that the overemphasis by commentators on the terms mis- and dis-information encourages either / or scenarios where people are set up in binary opposition; those who are consuming (correct) information and those who remain misinformed.

“This leaves very little space to entertain the idea that there might be individuals who are neither pro nor anti COVID-19 vaccines, but instead are questioning many of the so-called indisputable ‘truths’ – and therefore not just one truth such as the safety of COVID-19 vaccines,” said Dr Chandok.

Any dialogue on COVID-19 vaccine hesitancy, they say, is incomplete without acknowledging the Rashomon Effect, a term used in film, science and law dealing with themes of fractured truths, subjective realities and unreliable sources which, arguably, characterise the postmodern world.

The researchers also say that the overemphasis on ethnicity can be stigmatising. “It is worth considering the ways in which certain psychographics such as interests, attitudes and lifestyles might also contribute to vaccine hesitancy and scepticism among South Asian communities,” added Dr Chandok.

Notes to editors

A qualitative study of factors influencing COVID-19 vaccine hesitancy among South Asians in London (DOI: 10.1177/20542704221123430), by Raj S. Chandok, Poonam Madar and Azeem Majeed, will be published by JRSM Open at 00:05 hrs (UK time) on Wednesday 5 October 2022.

The link for the full text of the paper when published will be:

For further information or a copy of the paper please contact:

Rosalind Dewar
Media Office, Royal Society of Medicine
DL: +44 (0) 1580 764713
M: +44 (0) 7785 182732

JRSM Open is a peer reviewed online-only journal that follows the open-access publishing model. It is a companion journal to the Journal of the Royal Society of Medicine. JRSM Open publishes research papers, research letters, clinical and methodological reviews, and case reports. Its aim is to inform practice and policy making in clinical medicine. JRSM Open is editorially independent from the Royal Society of Medicine, and its editor is Professor Kamran Abbasi.

JRSM Open is a journal of the Royal Society of Medicine and it is published by SAGE Publishing.

Sara Miller McCune founded SAGE Publishing in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE is a leading international provider of innovative, high-quality content publishing more than 1000 journals and over 800 new books each year, spanning a wide range of subject areas. A growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne.

Skip to top